SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-534084"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-534084" > Risk of prostate ca...

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro (författare)
Uppsala universitet,Institutionen för kirurgiska vetenskaper,IRCCS, Osped San Raffaele, Unit Urol, Div Expt Oncol, Milan, Italy.,San Raffaele Hospital
Liedberg, Fredrik (författare)
Skane Univ Hosp, Dept Urol, Malmö, Sweden.;Lund Univ, Inst Translat Med, Malmö, Sweden.,Urothelial cancer,LUCC: Lund University Cancer Centre,Urology - urothelial cancer, Malmö,Urinblåsecancer,LUCC: Lunds universitets cancercentrum,Urologi - blåscancer, Malmö,Skåne University Hospital
Garmo, Hans (författare)
Uppsala universitet,Institutionen för kirurgiska vetenskaper,Uppsala University
visa fler...
Wilberg Orrason, Andri (författare)
Uppsala universitet,Urologkirurgi,Uppsala University
Stattin, Pär (författare)
Uppsala universitet,Urologkirurgi,Uppsala University
Westerberg, Marcus, 1990- (författare)
Uppsala universitet,Urologkirurgi,Uppsala Univ Hosp, Reg Canc Ctr Midsweden, SE-75237 Uppsala, Sweden.,Uppsala University
visa färre...
 (creator_code:org_t)
2024-05-13
2024
Engelska.
Ingår i: Scandinavian journal of urology. - : Medical Journals Sweden. - 2168-1805 .- 2168-1813 .- 1651-2537. ; 59, s. 98-103
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background and aims: One out of three men who undergo cystoprostatectomy for bladder cancer is diagnosed with incidental prostate cancer (PCa) at histopathological examination. Many of these men are PSA tested as part of their follow-up, but it is unclear if this is needed. The aim of this study was to assess the risk of PCa death in these men and the need of PSA-testing during follow-up.Methods: Between 2002 and 2020, 1,554 men were diagnosed with PCa after cystoprostatectomy performed for non -metastatic bladder cancer and registered in the National Prostate Cancer Register (NPCR) of Sweden. We assessed their risk of death from PCa, bladder cancer and other causes up to 15 years after diagnosis by use of data in The Cause of Death Register. The use of androgen deprivation therapy (ADT) as a proxy for PCa progression was assessed by fillings in The Prescribed Drug Register.Results: Fifteen years after diagnosis, cumulative incidence of death from PCa was 2.6% (95% CI 2.3%- 2.9%), from bladder cancer 32% (95% CI: 30%-34%) and from other causes 40% (95% CI: 36%-44%). Only 35% of men with PCa recorded as primary cause of death in The Cause of Death Register had started ADT before date of death, indicating sticky -diagnosis bias with inflated risk of PCa death.Conclusions: For a large majority of men diagnosed with incidental PCa at cystoprostatectomy performed for bladder cancer, the risk of PCa death is very small so there is no rationale for PSA testing during follow-up.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Bladder cancer
cystoprostatectomy
incidental prostate cancer
risk of death

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst. Hantera kakor

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy